GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics
Davide Zecchin(The Francis Crick Institute), Veronica A. Kinsler(Great Ormond Street Hospital)
Cited by 21
Related Papers
Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis
|Journal of Investigative Dermatology|2016|185
<i>BRAF</i> V600E Is a Determinant of Sensitivity to Proteasome Inhibitors
|Molecular Cancer Therapeutics|2013|20